Clinical Trials Directory

Trials / Sponsors / Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

Industry · 14 registered clinical trials7 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Melanoma (Skin Cancer), Unresectable Melanoma, Metastatic Melanoma
Phase 22025-11-28
RecruitingA Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive L
Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
Phase 1 / Phase 22025-03-11
RecruitingA Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Endometrial Cancer
Phase 22024-10-29
Active Not RecruitingStudy of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Soft Tissue Sarcoma, Primary Central Nervous System Carcinoma, Melanoma
Phase 12024-03-28
RecruitingStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants W
Metastatic Melanoma, Unresectable Melanoma, Melanoma
Phase 32023-03-30
RecruitingA Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresecta
Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer
Phase 1 / Phase 22022-07-20
RecruitingAutologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Phase 22021-05-07
CompletedStudy of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 12020-02-19
RecruitingStudy of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer
Phase 22019-05-07
WithdrawnStudy of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Ca
Non Small Cell Lung Cancer
Phase 22018-02-28
TerminatedStudy of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinom
Cervical Carcinoma
Phase 22017-06-22
CompletedStudy of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinom
Squamous Cell Carcinoma of the Head and Neck
Phase 22017-01-09
CompletedStudy of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Met
Metastatic Melanoma
Phase 22015-09-24
AvailableExpanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Unresectable Melanoma, Metastatic Melanoma